Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer

Published:2023-08-13 Issue:9 Volume:23 Page:913-926
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Loh Jerold¹,Low Jia Li¹,Sachdeva Manavi¹,Low Peter QJ¹,Wong Rachel Su Jen¹,Huang Yiqing¹,Chia Puey Ling²,Soo Ross A¹

Affiliation:

1. Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), National University Health System, Singapore, Singapore

2. Department of Medical Oncology, Tan Tock Seng Hospital, Singapore, Singapore

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2245140

Reference127 articles.

1. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

2. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007

3. Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract

4. Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

5. Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of chemoradiotherapy and immunotherapy in stage III NSCLC;Pathology and Oncology Research;2024-04-19